findmyKOL
Clinical trialNCT00270218CompletedPhase 1Interventional

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment66HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alabama Vaccine Crs

    Birmingham, Alabama, United States

  • San Francisco Vaccine and Prevention Crs

    San Francisco, California, United States

  • Hiv Prevention & Treatment Crs

    New York, New York, United States

  • Ny Blood Ctr./union Square Crs

    New York, New York, United States

  • Univ. of Rochester Hvtn Crs

    Rochester, New York, United States

  • Vanderbilt Vaccine Crs

    Nashville, Tennessee, United States

  • Fhcrc/uw Vaccine Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2006
Primary completion
Completion
31 Aug 2007
Last update posted
14 Oct 2021
Registered enrollment
66
Registry id
NCT00270218

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.